GGI
TEVA icon

Godsey & Gibb Inc’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Godsey & Gibb Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$713 Buy
+18
New +$644 ﹤0.01% 443
2024
Q1 		– Sell
-2,000
Closed -$20.9K – 419
2023
Q4 		$20.9K Buy
+2,000
New +$18.7K ﹤0.01% 218

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
CA
Continental Advisors Park City, Utah $233M AUM 14.5% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
RWA
Redhawk Wealth Advisors Minneapolis, Minnesota $987M AUM 25.25% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.2B AUM 15.74% 1-Year Est. Return

Godsey & Gibb Inc's TEVA Position: Q3 2026 in Review

Godsey & Gibb Inc opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 18 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #443 among its holdings. This is a return to the name: Godsey & Gibb Inc previously reported a position in TEVA as recently as Q4 2023.

Godsey & Gibb Inc first reported a position in TEVA in Q4 2023 and has held it in 2 quarters since. The position peaked at $20.9K in Q4 2023. 39 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Godsey & Gibb Inc held 18 shares of Teva Pharmaceutical Industries Limited worth $713 as of Q3 2026.
  • Teva Pharmaceutical Industries Limited was a new Godsey & Gibb Inc position in Q3 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q3 2026, its #443 holding.
  • Godsey & Gibb Inc first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and has held it in 2 quarters since.
  • Godsey & Gibb Inc's Teva Pharmaceutical Industries Limited position peaked at $20.9K in Q4 2023.
  • 39 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Godsey & Gibb Inc's 13F filing for Q3 2026, filed 14 Oct 2026.